Skip to main content
Premium Trial:

Request an Annual Quote

NCGR, 454, JGI, and Partners Awarded $3M to Sequence Fungal Crop Pathogen

NEW YORK, Dec. 14 (GenomeWeb News) - The National Center for Genome Resources said today that it will partner with 454 Life Sciences, the Department of Energy's Joint Genome Institute, Ohio State University, and the University of Tennessee to sequence the genome of Phytophthora capsici, a vegetable crop pathogen.


NCGR said that the groups have been awarded a total of $3 million from the US Department of Agriculture, the National Science Foundation, and the DOE Community Sequencing Program to sequence the genome of the organism, which it described as "a fungus-like oomycete" that destroys vegetable crops such as cucumber, squash, pumpkin, tomato, and pepper.


454 Life Sciences will perform the sequencing at its Measurement Service Center in Branford, Conn. The genome of P. capsici is around 65 million bases.


The collaborators will provide sequence information on the organism through the Phytophthora Functional Genomics Database.


The partners did not provide a timeline for when the sequencing project will be completed.

The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.